M. Sładek

发表

Malignancy and mortality in paediatric‐onset inflammatory bowel disease: a 3‐year prospective, multinational study from the paediatric IBD Porto group of ESPGHAN

G. Veres, P. Lionetti, K. Kolho, 2018, Alimentary Pharmacology and Therapeutics.

Vaccinations and Immunization Status in Pediatric Inflammatory Bowel Disease: A Multicenter Study From the Pediatric IBD Porto Group of the ESPGHAN.

G. Veres, E. Miele, C. Strisciuglio, 2020, Inflammatory bowel diseases.

Comparison of Outcomes Parameters for Induction of Remission in New Onset Pediatric Crohn's Disease: Evaluation of the Porto IBD Group “Growth Relapse and Outcomes with Therapy” (GROWTH CD) Study

G. Veres, A. Staiano, K. Kolho, 2014, Inflammatory bowel diseases.

Characteristics of clinical presentation of 146 cases of newly diagnosed paediatric onset Crohn’s disease

A. Ćmiel, M. Sładek, 2011 .

Induction and Maintenance Infliximab Therapy for the Treatment of Crohn's Disease with Perianal Fistulas in Children: Retrospective, Multicenter Study.

P. Jankowski, A. Szaflarska-Popławska, B. Iwańczak, 2016, Advances in clinical and experimental medicine : official organ Wroclaw Medical University.

Serum Concentrations of VEGF and TGF-&bgr;1 During Exclusive Enteral Nutrition in IBD

U. Jedynak-Wąsowicz, A. Wędrychowicz, P. Tomasik, 2011, Journal of pediatric gastroenterology and nutrition.

Inﬂiximab Therapy Could Decrease the Risk of the Development of Thyroid Disorders in Pediatric Patients With Crohn’s Disease

J. Starzyk, A. Wędrychowicz, A. Wędrychowicz, 2020 .

G. Veres, R. Russell, V. Wolters, 2019, Journal of pediatric gastroenterology and nutrition.

Successful treatment of infliximab-induced psoriasiform skin lesions despite biologic therapy intensification in a paediatric patient with Crohn’s disease and primary sclerosing cholangitis

M. Sładek, A. Wasilewska, Małgorzata Chmielowska-Trybek, 2021, Pediatria Polska.

Monotherapy With Infliximab Versus Combination Therapy in the Maintenance of Clinical Remission in Children With Moderate to Severe Crohn Disease

M. Dądalski, J. Kierkuś, E. Czkwianianc, 2015, Journal of pediatric gastroenterology and nutrition.

Serum anti-glycan antibodies in paediatric-onset Crohn's disease: association with disease phenotype and diagnostic accuracy

A. Ćmiel, M. Sładek, A. Wasilewska, 2014, Przeglad gastroenterologiczny.

Evaluation of the infliximab therapy of severe form of pediatric Crohn's disease in Poland: Retrospective, multicenter studies.

P. Jankowski, A. Szaflarska-Popławska, B. Iwańczak, 2017, Advances in clinical and experimental medicine : official organ Wroclaw Medical University.

Malignancy and Mortality in Pediatric Patients with Inflammatory Bowel Disease: A Multinational Study from the Porto Pediatric IBD Group

G. Veres, P. Lionetti, K. Kolho, 2014, Inflammatory bowel diseases.

Atypical Disease Phenotypes in Pediatric Ulcerative Colitis: 5-year Analyses of the EUROKIDS Registry

D. Turner, S. Cucchiara, A. Levine, 2012, Inflammatory bowel diseases.

Mucosal bacterial microflora and mucus layer thickness in adolescents with inflammatory bowel disease.

P. Adamski, T. Gosiewski, P. Heczko, 2009, World journal of gastroenterology.

Magnetic Resonance Enterography Cannot Replace Upper Endoscopy in Pediatric Crohn Disease: An Imagekids Sub-study

A. Griffiths, R. Baldassano, B. Weiss, 2017, Journal of pediatric gastroenterology and nutrition.

Azithromycin and metronidazole versus metronidazole-based therapy for the induction of remission in mild to moderate paediatric Crohn’s disease : a randomised controlled trial

M. Boaz, A. Bousvaros, J. Kierkuś, 2018, Gut.

[The low prevalence of Helicobacter pylori gastritis in newly diagnosed inflammatory bowel disease children and adolescent].

U. Jedynak-Wąsowicz, A. Wędrychowicz, S. Pieczarkowski, 2007, Przeglad lekarski.

ESPGHAN Revised Porto Criteria for the Diagnosis of Inflammatory Bowel Disease in Children and Adolescents

G. Veres, R. Russell, A. Staiano, 2013, Journal of pediatric gastroenterology and nutrition.

Prolonged Hypoxemia Enhances and Acute Hypoxemia Attenuates Laryngeal Reflex Apnea in Young Lambs

R. Parker, J. Grøgaard, H. Sundell, 1993, Pediatric Research.

Long-Lasting Effect of Prolonged Hypoxemia after Birth on the Immediate Ventilatory Response to Changes in Arterial Partial Pressure of Oxygen in Young Lambs

R. Parker, H. Sundell, M. Sładek, 1993, Pediatric Research.

Simple Endoscopic Score of Crohn's disease and Magnetic Resonance Enterography in Children: Report from ImageKids study.

A. Griffiths, M. Amitai, M. Gavish, 2019, Journal of pediatric gastroenterology and nutrition.

A Simple Endoscopic Score Modified for the Upper Gastrointestinal Tract in Crohn’s Disease [UGI-SES-CD]: A Report From the ImageKids Study

A. Griffiths, J. Kelsen, M. Amitai, 2018, Journal of Crohn's & colitis.

Results of the 2nd scientific workshop of the ECCO (IV): therapeutic strategies to enhance intestinal healing in inflammatory bowel disease.

A. Griffiths, G. D'Haens, G. Van Assche, 2012, Journal of Crohn's & colitis.

Prediction of thiopurine failure in pediatric Crohn’s disease: pediatric IBD Porto group of ESPGHAN

G. Veres, K. Kolho, T. D. de Meij, 2022, Pediatric Research.

Rapid Test for Fecal Calprotectin Levels in Children With Crohn Disease

G. Veres, A. Staiano, D. Turner, 2012, Journal of pediatric gastroenterology and nutrition.

Solitary rectal ulcer syndrome and enterocele in a 13-year-old boy

S. Pieczarkowski, K. Fyderek, M. Sładek, 2013 .

Fecal Markers of Inflammation and Disease Activity in Paediatric Crohn's Disease: Results from the ImageKids Study.

A. Griffiths, M. Gavish, T. Walters, 2019, Journal of pediatric gastroenterology and nutrition.

Horizontal Distribution of the Fecal Microbiota in Adolescents With Inflammatory Bowel Disease

P. Adamski, T. Gosiewski, P. Heczko, 2012, Journal of pediatric gastroenterology and nutrition.

Response to treatment is more important than disease severity at diagnosis for prediction of early relapse in new‐onset paediatric Crohn’s disease

G. Veres, R. Russell, E. Miele, 2018, Alimentary pharmacology & therapeutics.

Assessment of induction therapy with infliximab in children with moderate to severe ulcerative colitis: a multi-center study.

A. Wiernicka, M. Dądalski, J. Kierkuś, 2016, Developmental period medicine.

Orofacial Granulomatosis associated with Crohn's Disease: a multi-centre case series.

T. Molnár, N. D. de Boer, B. Verstockt, 2021, Journal of Crohn's & colitis.

P0643 EPIDEMIOLOGY OF ULCERATIVE COLITIS IN CHILDREN IN SOUTHERN POLAND: RETROSPECTIVE STUDY 1992???2002

U. Jedynak-Wąsowicz, K. Przybyszewska, Z. Guła, 2004 .

Infliximab Therapy Could Decrease the Risk of the Development of Thyroid Disorders in Pediatric Patients With Crohn's Disease

J. Starzyk, A. Wędrychowicz, A. Wędrychowicz, 2020, Frontiers in Endocrinology.

P525 Efficacy infliximab with immunomodulator and infliximab alone of maintenance therapy in children with Crohn's disease – multicenter randomized study

M. Dądalski, J. Kierkuś, E. Czkwianianc, 2013 .

Treatment-Specific Composition of Gut Microbiota Is Associated with Disease Remission in a Pediatric Crohn’s Disease Cohort

D. Relman, S. Holmes, S. Snapper, 2018, bioRxiv.

Surfactant Improves Gas Mixing and Alveolar Ventilation in Preterm Lambs

K. Sandberg, H. Sundell, A. Silberberg, 1991, Pediatric Research.

Prediction of thiopurine failure in pediatric Crohn’s disease: pediatric IBD Porto group of ESPGHAN

G. Veres, K. Kolho, T. D. de Meij, 2022, Pediatric Research.

Treatment-Specific Composition of the Gut Microbiota Is Associated With Disease Remission in a Pediatric Crohn's Disease Cohort.

D. Relman, A. Bousvaros, J. Escher, 2019, Inflammatory bowel diseases.

Malignancy and mortality in paediatric‐onset inflammatory bowel disease: a 3‐year prospective, multinational study from the paediatric IBD Porto group of ESPGHAN

P. Lionetti, K. Kolho, S. Koletzko, 2018, Alimentary pharmacology & therapeutics.